New Game and Wearable Wristband Developed in Collaboration with
Leading Digital Partners Offer Interactive Approaches to Hemophilia
Education and Activity Tracking in the US
NEW YORK--(BUSINESS WIRE)--
Pfizer Inc. (NYSE:PFE) today announced the launch of Hemocraft™,
a modification of the popular video game Minecraft®, and the
HemMobile® Striiv® Wearable, a custom wristband,
to help people living with hemophilia better approach hemophilia
education and activity tracking in the US. Hemophilia is a rare bleeding
disorder in which the body is unable to properly create a blood clot,
affecting 20,000 people in the US and an estimated 400,000 people
worldwide.1,2
“These new digital innovations can be integrated into everyday routines
to help empower people with hemophilia to learn about and track
different aspects relevant to their disease so that they can have
informed conversations with their health care providers,” said Dr. Kevin
W. Williams, Chief Medical Officer, Pfizer Rare Disease. “Ongoing
innovation, coupled with our research, and support programs, continue to
allow Pfizer to positively impact patients’ lives and pioneer a new era
in hemophilia—today, and in the future.”
Hemocraft and the HemMobile Striiv Wearable will be featured
at the National Hemophilia Foundation’s 69th Annual Meeting
in Chicago, the largest US gathering of hemophilia patients and
caregivers, August 24-26, 2017.
Hemocraft™
Hemocraft was created in partnership with the Entrepreneurial
Game Studio at Drexel University and representatives from the hemophilia
community. This game aims to help younger individuals with hemophilia,
8-16 years of age, learn the importance of integrating treatment into
their routine in an educational and fun gaming environment.
In Hemocraft, players go on a quest and interact with the village
doctor–a fictional health care professional character–to learn how to
stick to their treatment plan, stay prepared, and understand how
treatment works. Throughout the game, players are challenged to monitor
factor levels and self-infuse to help control bleeding, if needed. The
downloadable modification is available via HEMOCRAFTQuest.com.
“We are excited to see fun and educational tools that help people with a
bleeding disorder, but equally as important, their friends and family to
better understand the concept of factor levels in being able to stay
active, and stay in the game,” said Kate Nammacher, Senior Director of
Education, National Hemophilia Foundation.
HemMobile® Striiv®
Wearable
The HemMobile Striiv Wearable, the first wearable made for
patients with hemophilia, offers an easy-to-use, comprehensive tool to
track activity. The device, which can be worn on the wrist, has several
useful features including tracking daily activity levels and monitoring
heart rate to measure intensity. The wristband integrates with Pfizer’s
existing HemMobile® app, which allows users to log bleeds and
infusions, monitor their factor supply, and set appointment reminders.
The data captured generate personalized reports to provide a user’s
health care team with insights that can help guide the discussion
between a physician and their patient.
The HemMobile Striiv Wearable is available at no charge to anyone
diagnosed with hemophilia in the US, regardless of what treatment they
use, and more information about ordering can be found at patients’
doctors’ offices or hemophilia treatment centers.
Pfizer has developed partnerships with a number of organizations–like
Striiv and Drexel University–to provide programs and offerings that can
help to make an impact, including the Pfizer Community Connections
program, Pfizer Hemophilia Connect, and HemophiliaVillage.com.
Patients should consult with their health care professional about which
activities might be appropriate for them.
Pfizer Rare Disease
Rare disease includes some of the most serious of all illnesses and
impacts millions of patients worldwide,3 representing an
opportunity to apply our knowledge and expertise to help make a
significant impact on addressing unmet medical needs. The Pfizer focus
on rare disease builds on more than two decades of experience, a
dedicated research unit focusing on rare disease, and a global portfolio
of multiple medicines within a number of disease areas of focus,
including hematology, neuroscience, and inherited metabolic disorders.3
Pfizer Rare Disease combines pioneering science and deep understanding
of how diseases work with insights from innovative strategic
collaborations with academic researchers, patients, and other companies
to deliver transformative treatments and solutions. We innovate every
day leveraging our global footprint to accelerate the development and
delivery of groundbreaking medicines and the hope of cures.
Click here
to learn more about our Rare Disease portfolio and how we empower
patients, engage communities in our clinical development programs, and
support programs that heighten disease.
About HemMobile® and the HemMobile®
Striiv® Wearable
Launched in 2012 for iOS and Android devices, the HemMobile®
app is ranked as the #1 hemophilia app in the Apple App Store and
continues to be enhanced based on input and feedback from the hemophilia
community. The app is free and available, without the custom wearable
wristband, for download in the Google
Play™ store and Apple
App Store.
HemMobile 5.1 is the most recent app update specifically designed to
work with the Striiv custom wearable, offering additional functionality
for more accurate tracking and reporting to health care teams.
Disclaimer: Pfizer does not collect patient data through HemMobile or
the wearable. Striiv only collects anonymous, raw data for steps,
distance, activity minutes, acceleration levels, and calories through
the wearable. This data is not shared with any outside third parties,
including Pfizer. Users can choose to share data collected with their
health care provider, or others, at their own discretion. Pfizer and
Striiv do not have access to patient health records or other identifying
information.
Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies
to people that extend and significantly improve their lives. We strive
to set the standard for quality, safety and value in the discovery,
development and manufacture of health care products. Our global
portfolio includes medicines and vaccines as well as many of the world's
best-known consumer health care products. Every day, Pfizer colleagues
work across developed and emerging markets to advance wellness,
prevention, treatments and cures that challenge the most feared diseases
of our time. Consistent with our responsibility as one of the world's
premier innovative biopharmaceutical companies, we collaborate with
health care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all who
rely on us. We routinely post information that may be important to
investors on our website at www.pfizer.com.
In addition, to learn more, please visit us on www.pfizer.com
and follow us on Twitter at @Pfizer
and @Pfizer_News,
LinkedIn,
YouTube
and like us on Facebook at Facebook.com/Pfizer.
About the Entrepreneurial Game Studio at Drexel University
The Entrepreneurial Game Studio (EGS) at Drexel
is a game development studio and publisher focused on developing the
next generation of leaders in the mobile game industry. The EGS’s
mission is to become a factory for mobile game startups by providing a
safe and encouraging environment for students to develop and
commercialize their games. At the EGS, university students enjoy a
supportive work environment to create their games and refine business
strategies as they prepare to ship publicly.
Led by Dr. Frank Lee, who is well known for his work in transforming a
skyscraper in Philadelphia into the “World’s Largest Architectural Video
Game Display,” the EGS encourages people to see physical spaces
differently–by turning them into games! The studio is also dedicated to
teaching computer science through video game design. It has collaborated
with a number of local K-12 STEM education programs to help promote
interest and diversity in the field by building curiosity and excitement
about gaming. To learn about the EGS, visit: egs.excite.drexel.edu.
About Striiv
Striiv,
a recognized pioneer in custom health wearables, encourages behavior
change and delivers data insights to healthcare companies. Striiv is
dedicated to helping people improve their health by providing coaching
through the wearable and returning valuable biometric data to providers,
insurers, and physicians. From precision medicine to early detection of
various disease states, Striiv utilizes its advanced sensor technology
and algorithms to solve the most significant challenges facing
healthcare today.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170824005208/en/
Source: Pfizer Inc.